Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Causes, mechanisms and possible therapeutic targets of gout]Tobias ManigoldTherapeutische Umschau. Revue Therapeutique|November 7, 2024
[Calcium pyrophosphate deposition (CPPD) disease - more than just "pseudogout"]Tobias ManigoldDiagnostics (Basel, Switzerland)|April 12, 2025
Predominance of Calcium Pyrophosphate Crystals in Synovial Fluid Samples of Patients at a Large Tertiary CenterTobias Manigold, Alexander LeichtlePraxis|July 9, 2020
[CME-Rheuma 21: Precision Medicine - Synovial Biopsy in Rheumatology]Tobias Manigold, Giorgio TamborriniSwiss Medical Weekly|March 22, 2014
Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunologyTobias Manigold, Pablo VialThe Lancet. Infectious Diseases|November 30, 2007
T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversiesTobias Manigold, Vito RacanelliClinical Immunology (Orlando, Fla.)|June 2, 2007
Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcomeVito Racanelli, Tobias ManigoldBMC Rheumatology|June 4, 2026
Performance of a supervised nurse-led outpatient clinic for difficult-to-manage gout patients at a tertiary centerPiroska Maurer, Regina Herren, Tobias ManigoldZeitschrift Fur Rheumatologie|September 2, 2022
[Multiprofessional treatment approach in chronic back pain]Tobias Manigold, Brigitte E Gantschnig, Konrad StreitbergerArthritis Research & Therapy|November 4, 2017
TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotypeLilian Quero, Edveena Hanser, Tobias Manigold, et al.Pageof 3